Cargando…

Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report

In platelet-rich plasma (PRP) therapy, various growth factors and cytokines released the α-granules contained in platelets after activation can potentially enhance wound healing by delivering. We report a patient in whom treatment with PRP, prepared using a syringe-centrifugation-system PRP kit (KYO...

Descripción completa

Detalles Bibliográficos
Autores principales: Kushida, Satoshi, Kakudo, Natsuko, Morimoto, Naoki, Mori, Yudai, Kusumoto, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Open Science Company, LLC 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516017/
https://www.ncbi.nlm.nih.gov/pubmed/26221200
_version_ 1782383004721610752
author Kushida, Satoshi
Kakudo, Natsuko
Morimoto, Naoki
Mori, Yudai
Kusumoto, Kenji
author_facet Kushida, Satoshi
Kakudo, Natsuko
Morimoto, Naoki
Mori, Yudai
Kusumoto, Kenji
author_sort Kushida, Satoshi
collection PubMed
description In platelet-rich plasma (PRP) therapy, various growth factors and cytokines released the α-granules contained in platelets after activation can potentially enhance wound healing by delivering. We report a patient in whom treatment with PRP, prepared using a syringe-centrifugation-system PRP kit (KYOCERA Medical PRP Kit), for a fistula following bursitis of the lateral malleolus, which could not be healed with conventional wound therapy, led to successful healing. A 58-year-old man was on dialysis for type II diabetes and chronic renal failure. In the left lateral malleolus, septic bursitis developed, leading to a refractory fistula with a subcutaneous cavity measuring 4 × 3 cm, which persisted for more than 2 months. Platelet-rich plasma was prepared using the KYOCERA Medical PRP Kit (KYOCERA Medical Corporation, Osaka, Japan) and infused into the cavity twice to close it. After this procedure, the cavity size reduced, but the orifice and subcutaneous cavity were not closed. Therefore, additional PRP therapy was conducted after 10 weeks of the first PRP session. Complete closure was achieved 13 weeks after the first PRP therapy. In the present case, PRP was prepared using the KYOCERA Medical PRP Kit, and wound healing of a fistula with subcutaneous cavity following bursitis of the lateral malleolus was successfully cured. The KYOCERA Medical PRP Kit was useful, because PRP could be prepared simply and inexpensively using the syringe-centrifugation system.
format Online
Article
Text
id pubmed-4516017
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Open Science Company, LLC
record_format MEDLINE/PubMed
spelling pubmed-45160172015-07-28 Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report Kushida, Satoshi Kakudo, Natsuko Morimoto, Naoki Mori, Yudai Kusumoto, Kenji Eplasty Case Report In platelet-rich plasma (PRP) therapy, various growth factors and cytokines released the α-granules contained in platelets after activation can potentially enhance wound healing by delivering. We report a patient in whom treatment with PRP, prepared using a syringe-centrifugation-system PRP kit (KYOCERA Medical PRP Kit), for a fistula following bursitis of the lateral malleolus, which could not be healed with conventional wound therapy, led to successful healing. A 58-year-old man was on dialysis for type II diabetes and chronic renal failure. In the left lateral malleolus, septic bursitis developed, leading to a refractory fistula with a subcutaneous cavity measuring 4 × 3 cm, which persisted for more than 2 months. Platelet-rich plasma was prepared using the KYOCERA Medical PRP Kit (KYOCERA Medical Corporation, Osaka, Japan) and infused into the cavity twice to close it. After this procedure, the cavity size reduced, but the orifice and subcutaneous cavity were not closed. Therefore, additional PRP therapy was conducted after 10 weeks of the first PRP session. Complete closure was achieved 13 weeks after the first PRP therapy. In the present case, PRP was prepared using the KYOCERA Medical PRP Kit, and wound healing of a fistula with subcutaneous cavity following bursitis of the lateral malleolus was successfully cured. The KYOCERA Medical PRP Kit was useful, because PRP could be prepared simply and inexpensively using the syringe-centrifugation system. Open Science Company, LLC 2015-07-21 /pmc/articles/PMC4516017/ /pubmed/26221200 Text en Copyright © 2015 The Author(s) http://creativecommons.org/licenses/by/2.0/ This is an open-access article whereby the authors retain copyright of the work. The article is distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kushida, Satoshi
Kakudo, Natsuko
Morimoto, Naoki
Mori, Yudai
Kusumoto, Kenji
Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report
title Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report
title_full Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report
title_fullStr Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report
title_full_unstemmed Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report
title_short Utilization of Platelet-Rich Plasma for a Fistula With Subcutaneous Cavity Following Septic Bursitis: A Case Report
title_sort utilization of platelet-rich plasma for a fistula with subcutaneous cavity following septic bursitis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516017/
https://www.ncbi.nlm.nih.gov/pubmed/26221200
work_keys_str_mv AT kushidasatoshi utilizationofplateletrichplasmaforafistulawithsubcutaneouscavityfollowingsepticbursitisacasereport
AT kakudonatsuko utilizationofplateletrichplasmaforafistulawithsubcutaneouscavityfollowingsepticbursitisacasereport
AT morimotonaoki utilizationofplateletrichplasmaforafistulawithsubcutaneouscavityfollowingsepticbursitisacasereport
AT moriyudai utilizationofplateletrichplasmaforafistulawithsubcutaneouscavityfollowingsepticbursitisacasereport
AT kusumotokenji utilizationofplateletrichplasmaforafistulawithsubcutaneouscavityfollowingsepticbursitisacasereport